Corpus ID: 12605260

Gateways to clinical trials.

@article{Bayes2004GatewaysTC,
  title={Gateways to clinical trials.},
  author={M. Bayes and X. Rabasseda and J. Prous},
  journal={Methods and findings in experimental and clinical pharmacology},
  year={2004},
  volume={26 7},
  pages={
          587-612
        }
}
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.com. This issue focuses on the following selection of drugs: 101M, 166Ho-DOTMP, 3-AP; Abatacept, abetimus sodium, ACR-16, adefovir dipivoxil, alefacept, AMD-070, aminolevulinic acid hexyl ester… Expand

Paper Mentions

Interventional Clinical Trial
IRX-2 is designed to activate your own body's immune system so that it can better fight the invasion of head and neck cancer. In pre-clinical studies, IRX-2 has been shown to activate a… Expand
ConditionsSquamous Cell Carcinoma of the Head and Neck
InterventionBiological, Drug